FULBRYT Trademark

Trademark Overview


On Monday, September 20, 2021, a trademark application was filed for FULBRYT with the United States Patent and Trademark Office. The USPTO has given the FULBRYT trademark a serial number of 79325365. The federal status of this trademark filing is REGISTERED as of Tuesday, September 27, 2022. This trademark is owned by Boehringer Ingelheim International GmbH. The FULBRYT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparati...
fulbryt

General Information


Serial Number79325365
Word MarkFULBRYT
Filing DateMonday, September 20, 2021
Status700 - REGISTERED
Status DateTuesday, September 27, 2022
Registration Number6854752
Registration DateTuesday, September 27, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 12, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the alimentary tract and metabolism, and of the blood and blood forming organs; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, damaged skin and tissues; pharmaceutical preparations for the prevention and treatment of inflammation and inflammatory diseases and disorders; pharmaceutical preparations for the prevention and treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment and prevention of hormonal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases and disorders and viral infections; pharmaceutical preparations for the prevention and treatment of oncological and auto-immune diseases and disorders; cell based immune therapeutics being therapeutic pharamaceuticals for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases
Pseudo MarkFULBRIGHT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 22, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, January 25, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 25, 2023FINAL DISPOSITION PROCESSED
Tuesday, December 27, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 27, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 27, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, July 19, 2022NOTIFICATION PROCESSED BY IB
Tuesday, July 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 22, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, June 2, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 20, 2022REFUSAL PROCESSED BY IB
Friday, January 28, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, January 27, 2022REFUSAL PROCESSED BY MPU
Thursday, January 6, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 5, 2022NON-FINAL ACTION WRITTEN
Tuesday, January 4, 2022ASSIGNED TO EXAMINER
Friday, November 26, 2021APPLICATION FILING RECEIPT MAILED
Monday, November 22, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, November 22, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 11, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB